Bliss GVS Pharma Balans Gezondheid
Financiële gezondheid criteriumcontroles 6/6
Bliss GVS Pharma heeft een totaal eigen vermogen van ₹10.5B en een totale schuld van ₹832.9M, wat de schuld-eigenvermogensverhouding op 7.9% brengt. De totale activa en totale passiva bedragen respectievelijk ₹12.8B en ₹2.3B. De EBIT Bliss GVS Pharma is ₹1.2B waardoor de rentedekking -36.2 is. Het heeft contanten en kortetermijnbeleggingen van ₹2.2B.
Belangrijke informatie
7.9%
Verhouding schuld/eigen vermogen
₹832.88m
Schuld
| Rente dekkingsratio | -36.2x |
| Contant | ₹2.20b |
| Aandelen | ₹10.48b |
| Totaal verplichtingen | ₹2.34b |
| Totaal activa | ₹12.83b |
Recente financiële gezondheidsupdates
These 4 Measures Indicate That Bliss GVS Pharma (NSE:BLISSGVS) Is Using Debt Safely
Aug 25
Does Bliss GVS Pharma (NSE:BLISSGVS) Have A Healthy Balance Sheet?
Feb 20Does Bliss GVS Pharma (NSE:BLISSGVS) Have A Healthy Balance Sheet?
Jul 14These 4 Measures Indicate That Bliss GVS Pharma (NSE:BLISSGVS) Is Using Debt Reasonably Well
May 21Bliss GVS Pharma (NSE:BLISSGVS) Has A Pretty Healthy Balance Sheet
Feb 08Recent updates
Investors Don't See Light At End Of Bliss GVS Pharma Limited's (NSE:BLISSGVS) Tunnel
Nov 23Here's Why Bliss GVS Pharma (NSE:BLISSGVS) Has Caught The Eye Of Investors
Oct 26These 4 Measures Indicate That Bliss GVS Pharma (NSE:BLISSGVS) Is Using Debt Safely
Aug 25Bliss GVS Pharma Limited's (NSE:BLISSGVS) Prospects Need A Boost To Lift Shares
Aug 07Increases to Bliss GVS Pharma Limited's (NSE:BLISSGVS) CEO Compensation Might Cool off for now
Jul 19Bliss GVS Pharma's (NSE:BLISSGVS) Dividend Will Be ₹0.50
Jul 18Bliss GVS Pharma (NSE:BLISSGVS) Is Due To Pay A Dividend Of ₹0.50
Jul 04We Think Bliss GVS Pharma's (NSE:BLISSGVS) Solid Earnings Are Understated
May 10Bliss GVS Pharma Limited's (NSE:BLISSGVS) Price Is Right But Growth Is Lacking
Apr 27Does Bliss GVS Pharma (NSE:BLISSGVS) Have A Healthy Balance Sheet?
Feb 20There Is A Reason Bliss GVS Pharma Limited's (NSE:BLISSGVS) Price Is Undemanding
Jan 26Does Bliss GVS Pharma (NSE:BLISSGVS) Have A Healthy Balance Sheet?
Jul 14Bliss GVS Pharma (NSE:BLISSGVS) Has Affirmed Its Dividend Of ₹0.50
Sep 11Bliss GVS Pharma (NSE:BLISSGVS) Is Due To Pay A Dividend Of ₹0.50
Aug 28These 4 Measures Indicate That Bliss GVS Pharma (NSE:BLISSGVS) Is Using Debt Reasonably Well
May 21Estimating The Intrinsic Value Of Bliss GVS Pharma Limited (NSE:BLISSGVS)
Apr 08A Look At Bliss GVS Pharma's (NSE:BLISSGVS) Share Price Returns
Mar 18Here's How We Evaluate Bliss GVS Pharma Limited's (NSE:BLISSGVS) Dividend
Feb 25Bliss GVS Pharma (NSE:BLISSGVS) Has A Pretty Healthy Balance Sheet
Feb 08What Type Of Shareholders Make Up Bliss GVS Pharma Limited's (NSE:BLISSGVS) Share Registry?
Jan 21Do Its Financials Have Any Role To Play In Driving Bliss GVS Pharma Limited's (NSE:BLISSGVS) Stock Up Recently?
Jan 08How Is Bliss GVS Pharma's (NSE:BLISSGVS) CEO Paid Relative To Peers?
Dec 26
Did Bliss GVS Pharma's (NSE:BLISSGVS) Share Price Deserve to Gain 14%?
Dec 13Should You Use Bliss GVS Pharma's (NSE:BLISSGVS) Statutory Earnings To Analyse It?
Nov 30Bliss GVS Pharma Limited (NSE:BLISSGVS) Insiders Increased Their Holdings
Nov 18Does Bliss GVS Pharma Limited (NSE:BLISSGVS) Have A Place In Your Dividend Portfolio?
Nov 06Analyse van de financiële positie
Kortlopende schulden: De korte termijn activa ( ₹8.5B ) BLISSGVS } overtreffen de korte termijn passiva ( ₹1.9B ).
Langlopende schulden: De kortetermijnactiva BLISSGVS ( ₹8.5B ) overtreffen de langetermijnschulden ( ₹418.8M ).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: BLISSGVS heeft meer geld in kas dan de totale schuld.
Schuld verminderen: De schuld/eigen vermogen-ratio van BLISSGVS is de afgelopen 5 jaar gedaald van 12.9% naar 7.9%.
Schuldendekking: De schuld van BLISSGVS wordt goed gedekt door de operationele kasstroom ( 126.1% ).
Rentedekking: BLISSGVS verdient meer rente dan het betaalt, dus de dekking van rentebetalingen is geen probleem.